Amedisys Inc. (NASDAQ: AMED) saw hospice revenue and census growth as it awaits the final determination of its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. The company’s hospice segment earned $204 million during Q2 2024, up from $199.2 million year over year. Amedisys also saw a 0.4% increase in same-store average daily census […]
UnitedHealth Group’s (NYSE: UNH) subsidiary Optum, which holds a substantial home health and hospice business, continues to be a major driver of the company’s growth. Optum is in the process of acquiring the home health and hospice provider Amedisys (NASDAQ: AMED), with closing expected before the end of the year, pending some regulatory hurdles. Optum […]
The recent divestment of home health locations by Amedisys (NASDAQ: AMED) likely will give the company a smoother course towards closing its acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Last week, Amedisys announced the sale of the locations to the home health and hospice provider VitalCaring for an undisclosed amount, according to a […]
Amedisys (NASDAQ: AMED) has divested a number of home health locations in a sale to VitalCaring. VitalCaring also acquired some Unitedhealth Group (NYSE: UNH) care centers in the deal. Financial terms were undisclosed. Rumors of a potential divestiture began circulating in May. “On June 28, 2024, [Amedisys], UnitedHealth Group Incorporated and certain of their respective […]
Hospice staff training models with culturally appropriate LGBTQ+ components are key to improving quality outcomes among an increasingly diverse base of underserved seniors. Ongoing staff education and communication skill building are two significant pieces of bridging gaps of hospice care among LGBTQ+ seniors, according to Jerry Farmer, vice president of diversity, equity and inclusion at […]
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]
Amedisys Inc. (NASDAQ: AMED) has reportedly agreed to divest upwards of 100 home health and hospice locations to an undisclosed private equity buyer as the company addresses regulators’ antitrust concerns in its pending acquisition by the UnitedHealth Group’s (UNH) health care services arm Optum. The news came in a recent social media post from The […]
Amedisys Inc. (NASDAQ: AMED) has seen gains in its hospice segment as it waits for closure on its pending acquisition by Optum. The company’s hospice segment brought in $201 million in the first quarter of the year, up from $193.4 million year over year. Cost per day rose 2.3% during the quarter, however, largely due […]
Despite intensifying regulatory scrutiny on its deals, UnitedHealth Group (NYSE: UNH) remains poised for further acquisitions. During the past two years, the insurance giant has completed a slew of acquisitions spanning much of the health care continuum — including hospice, palliative care and home health — as well as health care technology, largely through its […]
Data are key to understanding how value-based care has helped highlight quality benefits of hospice. The U.S. Centers for Medicare & Medicaid Services (CMS) is sunsetting the hospice component of the value-based insurance design (VBID) as of Dec. 31. Commonly called the hospice carve-in, the program in 2021 began testing the coverage of hospice through […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
